Prenatal Screening Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Prenatal screening market analysis to 2036: explore market size, segments, diagnostics trends, pricing and company share. Identify opportunities and support strategy with GlobalData insights.
Understand the Future of the Prenatal Screening Market
Prenatal screening is a critical part of modern healthcare, enabling early detection of potential fetal health conditions. This report helps you understand how the market is evolving across diagnostics, technologies and geographies.
You will gain insight into how screening methods, including maternal serum screening and ultrasound, remain standard practice in many countries. Moreover, the report explores how both non-invasive and invasive techniques are shaping early detection strategies.
As a result, you can better assess how demand, technology and clinical practices are influencing the market.
Report Value Proposition – Why This Matters for You
This report goes beyond market data. It helps you interpret what trends in prenatal screening mean for your business, investment and strategy.
You can use it to:
- Identify growth opportunities across prenatal screening segments and technologies
- Evaluate market size, pricing trends and product usage across 39 countries
- Benchmark company performance and competitive positioning
- Support investment, licensing and partnership decisions
- Understand regulatory, reimbursement and healthcare system dynamics
In addition, the analysis is built on GlobalData’s proprietary market models and expert insights. It is trusted by Fortune 500 companies and leading governments worldwide.
Key Insights in Prenatal Screening Market Trends
Prenatal screening is widely used in developed markets for early detection of chromosomal abnormalities and neural tube defects. Screening approaches continue to rely on established methods such as maternal serum testing and ultrasound.
The report provides detailed quantitative and qualitative insights across 39 countries, supported by epidemiology-based market models. It includes data on market value, volume, product usage and average selling prices.
In addition, the analysis covers competitive dynamics, industry trends and company positioning. Analyst commentary provides further context to support interpretation of the data.

Scope
What You Will Learn
The report provides a structured view of the prenatal screening market, including:
- Market size, volume and pricing trends from 2015 to 2036
- Analysis across 39 countries with epidemiology-based insights
- Competitive landscape and company share analysis
- Regulatory frameworks and reimbursement policies
- Healthcare system overviews and market access insights
In addition, the report includes SWOT analysis and detailed qualitative insights to support decision-making.
Target Buyers for This Report
This report is designed for decision-makers who need clear, actionable insight:
- Diagnostics and medtech executives
- Healthcare and pharmaceutical strategy leaders
- Investors and private equity firms
- Procurement and sourcing professionals
- Market intelligence and research teams
If you are responsible for growth, investment or strategy, this report can support your decisions.
How Companies Use This Report
Organizations across healthcare and diagnostics can apply this report in practical ways:
- Diagnostics and medtech companies (e.g., Thermo Fisher Scientific, Siemens Healthineers)
Use it to evaluate product strategy, pricing and market positioning - Pharmaceutical and healthcare companies
Understand screening trends and align with diagnostic pathways - Investors and private equity firms
Assess market size, growth potential and competitive landscape - Procurement and sourcing teams
Evaluate supplier landscape and pricing dynamics across regions
As a result, you can move from data to more informed strategic decisions.
Reasons to Buy
Benchmark Against Global Leaders in Prenatal Screening
Understanding how leading companies are positioned is essential. Therefore, this report provides insights into market share, competitive landscape and company strategies.
You can benchmark your approach against major players such as Illumina Inc., Roche Diagnostics and Abbott Laboratories. This may help you identify gaps and refine your competitive strategy.
Built on Trusted Data and Expert Analysis
This report is backed by GlobalData’s proprietary research and analyst expertise.
- Built on GlobalData’s proprietary market models and datasets
- Trusted by Fortune 500 companies and government institutions
- Developed by analysts with deep healthcare and diagnostics expertise
Therefore, you can rely on the insights to support high-stakes decisions.
Act Now to Navigate Prenatal Screening Market Opportunities
The prenatal screening market is evolving across technologies, geographies and healthcare systems. However, competition and regulatory dynamics remain complex.
This report helps you understand where opportunities exist and how the market is structured.
Therefore, if you are evaluating investments, partnerships or expansion in prenatal screening, now is the time to act.
BGI Genomics Co Ltd
Yourgene Health Plc
Eurofins Scientific SE
Agilent Technologies Inc
Roche Diagnostics International Ltd
Revvity Inc
Beckman Coulter Inc
Abbott Laboratories
Siemens Healthineers AG
Quidel Corp
Thermo Fisher Scientific Inc
Tosoh Corp
Others
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
